Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman, Elyssa M. Campbell, Kee-Ming Chia, Qian Du, Geraldine Laven‐Law, Shalima S. Nair, Aliza Yong, Ashleigh Wilkinson, Samuel Clifton, Heloisa Helena Milioli, Sarah Alexandrou, Catherine Elizabeth Caldon, Jenny Z. Song, , Susan J. Clark
This study shows that Decitabine suppresses tumour growth in ER+ breast cancer by inducing DNA hypomethylation and altering 3D chromatin structure.
Nature Structural & Molecular Biology · Jan 5, 2024Peer-reviewedMolecular Biology